Jameleddine, M., Harzallah, N., Grati, H., Odabachian Jebali, M. C., Chemli, J., García Martí, S., . . . Hamouda, C. (2024). INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia. Web
Citación estilo ChicagoJameleddine, Mouna, Nabil Harzallah, Hela Grati, Marie Christine Odabachian Jebali, Jaafar Chemli, Sebastián García Martí, Natalie Soto, Andres Pichón-Riviere, and Chokri Hamouda. INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia. 2024.
Cita MLAJameleddine, Mouna, et al. INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia. 2024.
Precaución: Estas citas no son 100% exactas.